Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 10.55
-0.30 (-2.76%)
Mar 13, 2026, 3:28 PM CET
94.65% (1Y)
| Market Cap | 811.30M +134.0% |
| Revenue (ttm) | n/a |
| Net Income | -59.98M |
| EPS | -0.88 |
| Shares Out | 76.90M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 41,199 |
| Average Volume | 63,826 |
| Open | 10.50 |
| Previous Close | 10.85 |
| Day's Range | 10.25 - 10.70 |
| 52-Week Range | 4.55 - 11.90 |
| Beta | -0.46 |
| RSI | 67.90 |
| Earnings Date | Mar 24, 2026 |